Zepp Health Corp

Zepp Health Corp(ZEPP)股票分析

$2.610

-0.049 (-1.88%)收盘时

Loading chart…
最高
2.690
开盘
2.625
成交量加权均价
2.61
成交量
79.97K
市值
35.99M
最低
2.520
成交额
208.47K
企业价值/息税折旧摊销前利润(TTM)
-2.38

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has one reportable segment: Amazfit-branded products.

AI 分析 of Zepp Health Corp (ZEPP)

持有

Currently, Zepp Health Corp (ZEPP) is not a strong buy due to significant financial losses and declining revenue expectations. The current price is $2.61, with a forward P/E ratio of 3.124, suggesting the stock is undervalued, but the company has reported a widening net loss of $11.33 million in Q2 2026. The RSI is extremely low at 3.019, indicating oversold conditions, but this does not guarantee a price recovery. The main risk is the anticipated decline in Q3 2026 revenues, projected between $68 million and $73 million, down from $75.8 million in Q3 2025, which reflects potential market demand challenges.

估值指标

Zepp Health Corp(ZEPP)当前预期市盈率为 3.12,5 年平均预期市盈率为 -38.29。

预期市盈率

合理
5 年均值 P/E
-38.29
当前P/E
3.12
高估
83.56
低估
-160.15

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-11.70
当前EV/EBITDA
-2.38
高估
22.12
低估
-45.51

预期市销率

合理
5 年均值 P/S
0.37
当前P/S
0.02
高估
0.95
低估
-0.22

持有 ZEPP 的大户

T

Trivest Advisors Ltd

+ 持有ZEPP

-13.09%

3个月收益率

事件时间线

2026-09-22 (ET)

07:30:00

Amazfit Launches T-Rex Dual Solar Smartwatch at $649.99

2026-06-08 (ET)

21:40:00

Q1 Revenue Reaches $51.5 Million

2026-05-13 (ET)

07:30:00

Amazfit Launches Cheetah 2 Ultra at $599.99

2026-04-16 (ET)

07:10:00

Amazfit Launches Cheetah 2 Pro Sports Watch at $449.99

2026-04-15 (ET)

07:10:00

Zepp Health Signs Three-Year Global Partnership with HYROX

资讯

ZEPP 常见问题 —— 由 Alphio AI 解答

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has one reportable segment: Amazfit-branded products. It operates in the Technology sector (ELECTRONIC COMPUTERS industry).

Currently, Zepp Health Corp (ZEPP) is not a strong buy due to significant financial losses and declining revenue expectations. The current price is $2.61, with a forward P/E ratio of 3.124, suggesting the stock is undervalued, but the company has reported a widening net loss of $11.33 million in Q2 2026. The RSI is extremely low at 3.019, indicating oversold conditions, but this does not guarantee a price recovery. The main risk is the anticipated decline in Q3 2026 revenues, projected between $68 million and $73 million, down from $75.8 million in Q3 2025, which reflects potential market demand challenges.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易